Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial

Abstract Background The authors investigated the durability of vaccine efficacy (VE) against human papillomavirus (HPV)16 or 18 infections and antibody response among nonrandomly assigned women who received a single dose of the bivalent HPV vaccine compared with women who received multiple doses and...

Full description

Saved in:
Bibliographic Details
Published in:JNCI : Journal of the National Cancer Institute 2020-10, Vol.112 (10), p.1038-1046
Main Authors: Kreimer, Aimée R, Sampson, Joshua N, Porras, Carolina, Schiller, John T, Kemp, Troy, Herrero, Rolando, Wagner, Sarah, Boland, Joseph, Schussler, John, Lowy, Douglas R, Chanock, Stephen, Roberson, David, Sierra, Mónica S, Tsang, Sabrina H, Schiffman, Mark, Rodriguez, Ana Cecilia, Cortes, Bernal, Gail, Mitchell H, Hildesheim, Allan, Gonzalez, Paula, Pinto, Ligia A
Format: Article
Language:English
Subjects:
Adolescent
Adult
Antibodies
Antibodies, Viral - blood
Antibodies, Viral - immunology
Antibody response
Cervix
Confidence intervals
Costa Rica - epidemiology
Durability
Enzyme-linked immunosorbent assay
Female
Geography
Human papillomavirus
Human papillomavirus 16 - immunology
Human papillomavirus 16 - isolation & purification
Human papillomavirus 18 - immunology
Human papillomavirus 18 - isolation & purification
Humans
Immunization
Infections
Next-generation sequencing
Papillomavirus Infections - blood
Papillomavirus Infections - epidemiology
Papillomavirus Infections - prevention & control
Papillomavirus Infections - virology
Papillomavirus Vaccines - administration & dosage
Vaccination
Vaccine efficacy
Vaccines
Vaccines, Combined - administration & dosage
Virus-like particles
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!